Analyst firms · Morgan Stanley · NUE
Morgan Stanley NUE price target and rating history
Nucor Corporation (NUE) · Industrials
Morgan Stanley rates Nucor Corporation (NUE) Overweight with a $310 price target, as of its latest action on Nov 17, 2026. It has published 5 rating actions on NUE since October 2021, including 2 upgrades and 1 downgrade. Across 5 firms with a NUE price target in the last 12 months, the median target is $274. Morgan Stanley's $310 is 13% above that.
- Current rating
- Overweight
- Price target
- $310
- Median target, all firms
- $274
- Actions on NUE
- 5
Morgan Stanley price target on NUE
Every Morgan Stanley rating on NUE
- Nov 17, 2026
- Jan 9, 2026
- Aug 15, 2024
- Jan 31, 2022
- Oct 26, 2021
How other firms rate NUE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Overweight | $310 | Nov 17, 2026 |
| UBS | Buy | $307 | Nov 16, 2026 |
| CFRA | Hold | Nov 4, 2026 | |
| KeyBanc Capital Markets | Overweight | $274 | Jun 24, 2026 |
| Barclays | Overweight | $270 | May 22, 2026 |
| Goldman Sachs | Buy | $210 | Apr 1, 2026 |
Questions about Morgan Stanley and NUE
- What is Morgan Stanley's price target for NUE?
- Morgan Stanley's latest stated price target for Nucor Corporation (NUE) is $310, from its action on Nov 17, 2026.
- What is Morgan Stanley's rating on NUE?
- Morgan Stanley rates NUE Overweight, a bullish rating, as of Nov 17, 2026.
- When did Morgan Stanley last change its view on NUE?
- On Nov 17, 2026, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $310.
- How does Morgan Stanley's NUE target compare with other analysts?
- Across 5 firms with a NUE price target in the last 12 months, the median target is $274. Morgan Stanley's $310 is 13% above that.
More NUE rating histories
All Morgan Stanley ratingsNUE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.